← Browse by Condition
Medical Condition
idiopathic hypersomnia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Enrollment
96 pts
Location
United States, Canad...
Sponsor
Centessa Pharmaceuticals (UK) ...
NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Enrollment
90 pts
Location
United States
Sponsor
Centessa Pharmaceuticals (UK) ...
NCT01793168
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
Sanford Health